Cherry Huang is the President of Johnson & Johnson Innovative Medicine China and a member of Johnson & Johnson Innovative Medicine Asia Pacific leadership team.
Cherry brings an enterprise mindset and over 25 years of experience across multiple functions and markets at Johnson & Johnson. In her most recent role as Area Managing Director, North Asia, Cherry oversaw the business in South Korea, Hong Kong, and Taiwan. Under her leadership, the North Asia cluster delivered strong contributions to the region. Before taking this position, Cherry was Vice President for Finance, Johnson & Johnson Innovative Medicine Asia Pacific. Cherry was instrumental in setting business strategy and overseeing financial stewardship and supported various business initiatives.
Prior to this, Cherry held senior leadership positions in various business segments in markets across Southeast Asia, China, Europe and North America.
A firm believer in the power of collaboration, she dedicates her efforts to strengthening the innovation ecosystem and forging strategic partnerships with external communities. She has also committed her time to supporting the development of the local industry and in her recent role as Area Managing Director, North Asia she played an active role in the Korean Research-based Pharmaceutical Industry Association (KRPIA), working to enhance patient access to medical innovations.
Cherry is a Credo-based leader known for her strong business acumen, support for patient centric innovation, and passion for talent development. As a staunch advocate for Diversity, Equity, and Inclusion (DE&I), Cherry actively promotes a culture where all voices are heard and respected, creating an environment that fosters innovation and growth.
Cherry has an MBA from the Booth school of business, University of Chicago, and a Bachelor of Science degree from Shanghai Jiao Tong University.